Jyothy Labs saw muted Q4, PAT jumps 11% but margins shrink
  • WebDesk BTVI
  • May 08 2019

Ullas Kamath, Joint MD of Jyothy Laboratories, says the last quarter (Q4) was a little muted as their household insecticide business has not taken off due to seasonality. He says that barring that segment, business has grown by 9.3% in Q4 and 11% in FY19. Profit After Tax (PAT) has increased by 11%, he said. He adds that the company’s strategy for premiumisation of certain products will give good yields in FY20.